|

Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

RECRUITINGSponsored by Kardium Inc.
Actively Recruiting
SponsorKardium Inc.
Started2026-10-09
Est. completion2029-10
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites

Summary

This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Key Inclusion Criteria:

* Patients with a planned ablation procedure using the commercially available Globe PF System

Key Exclusion Criteria:

* Patients whose life expectancy is 1 year or less
* Contraindication to left atrial catheter ablation or PF ablation
* Current enrollment in any investigational study of a medical device, biologic, or drug not pre-approved by Kardium

Conditions2

Atrial FibrillationHeart Disease

Locations2 sites

Arkansas

1 site
Arrhythmia Research Group
Jonesboro, Arkansas, 72401
Devi Nair, MD

Washington

1 site
Overlake Hospital
Bellevue, Washington, 98004
Maheer Gandhavadi, MD

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.